Malvern PanalyticalREAD MORE
NanoTemper TechnologiesREAD MORE
Researchers Tackle the Surface Transmission of COVID-19 in New Partnership
A project to develop surface treatments that can provide long-lasting protection against the COVID-19 virus has been launched at the University of Birmingham.
AMSBIO Launches New Human iPSC-Derived Cells and iPSC Differentiation Reagent Kits
AMSBIO is launching a new range of human iPSC-derived cells and human iPSC differentiation reagent kits optimized for high-throughput experiments in areas including drug discovery and toxicity screening.
AMSBIO Announces StemFit® for Mesenchymal Stem Cells
AMSBIO announces StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells.
Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience
Antlia Bioscience, Inc., and XL-protein GmbH are pleased to announce a strategic slliance using XL-protein's proprietary PASylation® technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure.READ MORE
Iksuda Therapeutics Enters Agreement With University of Goettingen To Develop Novel Antibody Drug Conjugates
Iksuda Therapeutics (Iksuda), today announces it has executed its option to secure exclusive, worldwide rights to develop a novel class of tumour-activated prodrug payloads from the University of Goettingen, following a successful collaboration exemplifying the series in ADC formats.READ MORE
Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells
Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology, today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells.READ MORE
Mogrify Introduces EpiMOGRIFY To Identify Epigenetic Switches
Mogrify Limited (Mogrify®) today announced the introduction of EpiMOGRIFY. The platform models the epigenetic state of the cell to predict the switches important for cell identity, cell maintenance, directed differentiation and cell conversion.READ MORE
Solentim To Supply Cell Line Development Solutions for New R&D Center in San Francisco
Samsung’s new R&D facility in San Francisco will offer rapid, high-quality development services, including cell line development, to its global customers.READ MORE
The Native Antigen Company Launches SARS-CoV-2 Specific Antibodies
The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), today announced the introduction of ten new monoclonal antibodies recognising SARS-CoV-2, the causative agent of COVID-19.READ MORE
BD Secures FDA Clearance for New Automated Clinical Flow Cytometry Solution
The BD FACSDuet™ Sample Preparation System enables clinical laboratories to fully automate the sample to answer process and improve their efficiency, by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric™ Flow Cytometer.READ MORE